Krystal Biotech Inc (KRYS)
Fixed asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 296,569 | 55,764 | 498 | — | — |
| Property, plant and equipment | US$ in thousands | 155,168 | 161,202 | 161,684 | 112,355 | 30,876 |
| Fixed asset turnover | 1.91 | 0.35 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $296,569K ÷ $155,168K
= 1.91
Fixed asset turnover is a financial ratio that measures a company's ability to generate revenue from its investment in fixed assets. In the case of Krystal Biotech Inc, the fixed asset turnover has shown an improvement over the years.
In 2020 and 2021, the fixed asset turnover ratio was 0.00, indicating that the company was not efficiently utilizing its fixed assets to generate revenue. However, starting from 2022, there was a significant increase in the ratio, with a value of 0.35 in 2023 and 1.91 in 2024.
This improvement suggests that Krystal Biotech Inc has become more efficient in utilizing its fixed assets to generate sales, which is a positive sign for investors and stakeholders. It shows that the company has been able to increase its revenue without significantly increasing its investment in fixed assets, leading to better overall performance and profitability.
Peer comparison
Dec 31, 2024